Chapter 035

Immunotherapy

Anahid Jewett and Han-Ching Tseng

GENERAL REFERENCES

  1. Ahmadzadeh V, Farajnia S, Feizi MA, Nejad RA: Antibody humanization methods for development of therapeutic applications, Monoclon Antib Immunodiagn Immunother 33:67–73, 2014. PUBMED Abstract
  2. Choi J, et al.: Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP, Science 273:239–242, 1996. PUBMED Abstract
  3. Cronstein BN: Second-line antirheumatic drugs. In Snyderman R, Gallin JI, editors: Inflammation: basic principles and clinical correlates, Philadelphia, 1999, Lippincott Williams & Wilkins.
  4. Dinarello CA: Modalities for reducing interleukin 1 activity in disease, Trends Pharmacol Sci 14:155–159, 1993. PUBMED Abstract
  5. Dinarello CA: Interleukin-1: a proinflammatory cytokine. In Gallin JI, Snyderman R, editors: Inflammation: basic principles and clinical correlates, Philadelphia, 1999, Lippincott Williams & Wilkins.
  6. Goldstein AL, Low TL, McAdoo M: Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide, Proc Natl Acad Sci 74:725–729, 1977. PUBMED Abstract
  7. Janeway Jr C, Travers P: Immunobiology—the immune system in health and disease, ed 6, London, 2005, Garland.
  8. Jewett A, Tseng HC: Potential rescue, survival and differentiation of cancer stem cells and primary non-transformed stem cells by monocyte-induced split energy in natural killer cells, Cancer Immunol Immunother 61:265–274, 2012. PUBMED Abstract
  9. Jewett A, Tseng HC: Tumor microenvironment may shape the function and phenotype of NK cells through the induction of split anergy and generation of regulatory NK cells. In Shurin M, Umansky V, Malyguine A, editors: The tumor immunoenvironment, Springer, 2013, pp 361–384.
  10. Michalek SM, Childers NK: Development and outlook for a caries vaccine, Crit Rev Oral Biol Med 1:37–54, 1990. PUBMED Abstract
  11. Ohno M, Natsume A, Wakabayashi T: Cytokine therapy, Adv Exp Med Biol 746:86–94, 2012. PUBMED Abstract
  12. Tseng HC, Jewett A, Cacalano N: Split anergized Natural Killer cells halt inflammation by inducing stem cell differentiation, resistance to NK cell cytotoxicity and prevention of cytokine and chemokine secretion, OncoTarget 6:8947–8959, 2015. PUBMED Abstract
  13. Von Boehmer H, Melchers F: Checkpoints in lymphocyte development and autoimmune disease, Nat Immunol 11:14–20, 2010. PUBMED Abstract